← Leaderboards
Jun Yoshioka
Albert Einstein College Of Medicine, Inc
$3,131,975
Attributed
$4,309,299
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $785K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,309,299 · 3
By mechanism
R01$4,309,299 · 3
Top collaborators
- Richard N Kitsis4 shared
Most similar at Albert Einstein College Of Medicine, Inc
Same institution · by research overlap
- Andrea Gabriela Lopez-Arroyo$89,541
Others in their field
Top investigators on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$118,439,174
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
HeartKnowledge Of ResultsCardiac MyocytesMediatingInnovationCellsMolecularKnockout MiceIn VivoLinkPathway InteractionsPathogenesisSignal TransductionBindingCell DeathGenetic TranscriptionReconstitutionMutantTxnip GeneGlucose TransporterBiochemicalGenetic ManipulationMetabolicApoptosis
Grant awards (9)
Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart$392,500
R01 · FY2025 · HL · contact PI
Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathy$392,500
R01 · FY2025 · HL · contact PI
Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathy$392,500
R01 · FY2024 · HL · contact PI
Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart$384,650
R01 · FY2024 · HL · contact PI
Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart$392,500
R01 · FY2023 · HL · contact PI
A new molecular pathway for diabetic cardiomyopathy$581,525
R01 · FY2019 · HL
A new molecular pathway for diabetic cardiomyopathy$583,525
R01 · FY2018 · HL
A new molecular pathway for diabetic cardiomyopathy$585,489
R01 · FY2017 · HL
A new molecular pathway for diabetic cardiomyopathy$604,110
R01 · FY2016 · HL